Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective
Neurodegenerative diseases encompass a number of very heterogeneous disorders, primarily characterized by neuronal loss and a concomitant decline in neurological function. Examples of this type of clinical condition are Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease and Amyotrophic L...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/5/347 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850031390838489088 |
|---|---|
| author | Belén Calvo Pierre Schembri-Wismayer María Beatriz Durán-Alonso |
| author_facet | Belén Calvo Pierre Schembri-Wismayer María Beatriz Durán-Alonso |
| author_sort | Belén Calvo |
| collection | DOAJ |
| description | Neurodegenerative diseases encompass a number of very heterogeneous disorders, primarily characterized by neuronal loss and a concomitant decline in neurological function. Examples of this type of clinical condition are Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease and Amyotrophic Lateral Sclerosis. Age has been identified as a major risk in the etiology of these disorders, which explains their increased incidence in developed countries. Unfortunately, despite continued and intensive efforts, no cure has yet been found for any of these diseases; reliable markers that allow for an early diagnosis of the disease and the identification of key molecular events leading to disease onset and progression are lacking. Altered adult neurogenesis appears to precede the appearance of severe symptoms. Given the scarcity of human samples and the considerable differences with model species, increasingly complex human stem-cell-based models are being developed. These are shedding light on the molecular alterations that contribute to disease development, facilitating the identification of new clinical targets and providing a screening platform for the testing of candidate drugs. Moreover, the secretome and other promising features of these cell types are being explored, to use them as replacement cells of high plasticity or as co-adjuvant therapy in combinatorial treatments. |
| format | Article |
| id | doaj-art-dc13cc189d0649ffa5ae6781fe9926e9 |
| institution | DOAJ |
| issn | 2073-4409 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cells |
| spelling | doaj-art-dc13cc189d0649ffa5ae6781fe9926e92025-08-20T02:58:58ZengMDPI AGCells2073-44092025-02-0114534710.3390/cells14050347Age-Related Neurodegenerative Diseases: A Stem Cell’s PerspectiveBelén Calvo0Pierre Schembri-Wismayer1María Beatriz Durán-Alonso2Faculty of Health Sciences, Catholic University of Ávila, 05005 Ávila, SpainDepartment of Anatomy, Faculty of Medicine and Surgery, University of Malta, MSD 2080 Msida, MaltaDepartment of Biochemistry and Molecular Biology and Physiology, Faculty of Medicine, University of Valladolid, 47005 Valladolid, SpainNeurodegenerative diseases encompass a number of very heterogeneous disorders, primarily characterized by neuronal loss and a concomitant decline in neurological function. Examples of this type of clinical condition are Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease and Amyotrophic Lateral Sclerosis. Age has been identified as a major risk in the etiology of these disorders, which explains their increased incidence in developed countries. Unfortunately, despite continued and intensive efforts, no cure has yet been found for any of these diseases; reliable markers that allow for an early diagnosis of the disease and the identification of key molecular events leading to disease onset and progression are lacking. Altered adult neurogenesis appears to precede the appearance of severe symptoms. Given the scarcity of human samples and the considerable differences with model species, increasingly complex human stem-cell-based models are being developed. These are shedding light on the molecular alterations that contribute to disease development, facilitating the identification of new clinical targets and providing a screening platform for the testing of candidate drugs. Moreover, the secretome and other promising features of these cell types are being explored, to use them as replacement cells of high plasticity or as co-adjuvant therapy in combinatorial treatments.https://www.mdpi.com/2073-4409/14/5/347neurodegenerative disordersneural stem cellspluripotent stem cellsneurogenesiscell modelsstem-cell-based therapy |
| spellingShingle | Belén Calvo Pierre Schembri-Wismayer María Beatriz Durán-Alonso Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective Cells neurodegenerative disorders neural stem cells pluripotent stem cells neurogenesis cell models stem-cell-based therapy |
| title | Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective |
| title_full | Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective |
| title_fullStr | Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective |
| title_full_unstemmed | Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective |
| title_short | Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective |
| title_sort | age related neurodegenerative diseases a stem cell s perspective |
| topic | neurodegenerative disorders neural stem cells pluripotent stem cells neurogenesis cell models stem-cell-based therapy |
| url | https://www.mdpi.com/2073-4409/14/5/347 |
| work_keys_str_mv | AT belencalvo agerelatedneurodegenerativediseasesastemcellsperspective AT pierreschembriwismayer agerelatedneurodegenerativediseasesastemcellsperspective AT mariabeatrizduranalonso agerelatedneurodegenerativediseasesastemcellsperspective |